Medical Costs Related to Enzyme Replacement Therapy for Mucopolysaccharidosis Types I, II, and VI in Brazil: A Multicenter Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Medical Costs Related to Enzyme Replacement Therapy for Mucopolysaccharidosis Types I, II, and VI in Brazil: A Multicenter Study

Published:2015-12 Issue: Volume:8 Page:99-106
ISSN:2212-1099
Container-title:Value in Health Regional Issues
language:en
Short-container-title:Value in Health Regional Issues

Author:

Bitencourt Fernanda Hendges de,Vieira Taiane Alves,Steiner Carlos Eduardo,Neto Jordão Correa,Boy Raquel,Schwartz Ida Vanessa Doederlein

Publisher

Elsevier BV

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Reference32 articles.

1. The mucopolysaccharidoses;Neufeld,2001

2. Coutinho MF, Lacerda L, Alves S. Glycosaminoglycan storage disorders: a review. Biochem Res Int 2012;ID:471325.

3. Brain magnetic resonance imaging findings in patients with mucopolysaccharidosis VI;Azevedo;J Inherit Metab Dis,2013

4. The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK;Moore;Orphanet J Rare Dis,2008

5. Rede MPS. Brasil [homepage]. Available from: www.redempsbrasil.ufrgs.br/. [Accessed December 14, 2014].

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-invasive intravenous administration of AAV9 transducing iduronate sulfatase leads to global metabolic correction and prevention of neurologic deficits in a mouse model of Hunter syndrome;Molecular Genetics and Metabolism Reports;2023-03

2. Modern Approaches to the Management of Children with Mucopolysaccharidosis Type I;Pediatric pharmacology;2022-10-04

3. Gene Therapy of Mucopolysaccharidosis Type I Mice: Repeated Administrations and Safety Assessment of pIDUA/Nanoemulsion Complexes;Current Gene Therapy;2021-12-23

4. Medication Cost of Enzyme Replacement Therapy for Mucopolysaccharidoses in Iran;INT J PEDIATR-MASSHA;2021

5. Congenital Disorders Caused by Defects in Catabolism of Glycosaminoglycans;Trends in Glycoscience and Glycotechnology;2020-07-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3